AI assistant
Moderna, Inc. — Director's Dealing 2025
Aug 29, 2025
30610_dirs_2025-08-29_e217cd46-2202-4261-871f-fd5e152d38fe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2025-08-27
Reporting Person: Mock James M (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-27 | Common Stock | M | 774 | — | Acquired | 17715 | Direct |
| 2025-08-27 | Common Stock | F | 375 | $24.73 | Disposed | 17340 | Direct |
| 2025-08-28 | Common Stock | M | 329 | — | Acquired | 17669 | Direct |
| 2025-08-28 | Common Stock | F | 160 | $25.10 | Disposed | 17509 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-27 | Restricted Stock Units | $ | M | 774 | Disposed | Common Stock (774) | Direct | |
| 2025-08-28 | Restricted Stock Units | $ | M | 329 | Disposed | Common Stock (329) | Direct |
Footnotes
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F4: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.